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We present and characterize an original experimental model to create a chronic ischemic heart failure in pig. Two ameroid
constrictors were placed around the LAD and the circumﬂex artery. Two months after surgery, pigs presented a poor LV
function associated with a severe mitral valve insuﬃciency. Echocardiography analysis showed substantial anomalies in radial
and circumferential deformations, both on the anterior and lateral surface of the heart. These anomalies in function were coupled
with anomalies of perfusion observed in echocardiography after injection of contrast medium. No demonstration of myocardial
infarction was observed with histological analysis. Our ﬁndings suggest that we were able to create and to stabilize a chronic
ischemic heart failure model in the pig. This model represents a useful tool for the development of new medical or surgical
treatment in this ﬁeld.
1.Introduction
Ischemic cardiomyopathy plays a predominant part in the
etiology of patients with heart failure [1]. Despite the
progress in various types of treatment, despite the improve-
ment in many percutaneous revascularization techniques
[2], and despite the progress in coronary artery bypass
surgery [3], the cardiac surgeon is presented with many
patients with chronic ischemia who cannot beneﬁt from
revascularization techniques. Patients with heart failure
require frequent hospitalisation with a substantial rate of
mortality and represent a high cost to society [4, 5].
Cardiac surgeons take an ever greater leading role in the
management of these patients with the aim of trying to
reduce the morbidity and mortality rates. The development
of experimental models close to the clinical reality of a
patient with heart failure is a major approach to a better
understanding of the pathophysiological mechanisms set in
motion. This will take part in improving essential knowledge
with regard to heart failure, to imagine new therapeutic
concepts, whether medical or surgical. In the literature,
there are numerous models of heart failure, whether the
result of genetic modiﬁcation [6], of a permanent ligature of
the coronary arteries with, or without, reperfusion (models
of infarction and not of ischemia) [7–9], of electrical
stimulationatarapidrate[10],ofmodiﬁcationsofload[11],
or of toxic origin [12, 13]. On the other hand, some models
have been developed to induce myocardial ischemia without
heart failure [14]. These various models have enabled us to
improve our knowledge, but they do not go far enough in
meeting the clinical reality of a patient with heart failure
and ischemia. The aim of our study was to develop a model
for chronic ischemic heart failure which was stable and
reproducible. To be able to represent an interface and a tool
useablebyalltheprotagonistsgravitating aroundthisdisease
and to position it in the preclinical period, the model was2 Cardiology Research and Practice
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Figure 1: Study design.
set up in pigs. We present the development of a model for
chronic heart failure by double constriction of the coronary
artery(circumﬂexbranchofleftcoronaryarteryandanterior
descending branch) responsible for progressive stenoses.
2.MaterialandMethods
2.1. Animals. Male pigs, 2 months aged weighing 15 to
20kg were used for this procedure. These animals came
from an animal supply facility where they are housed pre-
and postoperatively and where the rules of good practice
with regard to the management of animals for research
a r em e t .T h i ss t u d yw a sc o n d u c t e di na c c o r d a n c ew i t h
both institutional guidelines and those in force in the
European community for experimental animal use (L358–
86/609/EEC).
2.2. Design of Study. Details of the design are given in
Figure 1.B ri e ﬂ y ,aﬁ r s te c h o c a r d i o gra p h yw a sp e r f o rm e dj u s t
before the surgery (baseline). The follow-up was targeted at
one and two months after the procedure. Parameters as well
as Left Ventricle (LV) function, LV geometry, wall motion
score, thickening, circumferential and longitudinal strain,
and analysis of the myocardial perfusion were stored and
compared.
2.3. Preparation and Anaesthesia. T h ea n i m a l sw e r ep r e -
medicated with an intramuscular injection of Calmivet
(Acepromazine, 0.5mL). They were then transferred to the
operating room. A catheter was placed in the vein at the
level of the left ear (cathlon 22 gauge) which enabled
induction of anaesthesia, combining Imalg` ene (30mg/kg-
ketamine) and Rompun (1mL/kg-xylazine). The pig was
then intubated with ano. 7 reinforced tube using a large
right blade laryngoscope. Ventilatory parameters were as
follows: frequency 15–20/min, Volume 8–10mL/kg. The pig
was placed in the dorsal recumbent position. Homeostasis
was maintained using a heated operating table, controlled by
at e m p e r a t u r ep r o b e .
2.4. Heart Failure Model: Double Constriction. An incision
was made into the thorax at the level of the left ﬁfth
intercostal space. The pericardium was opened radially on
contact with the left atrium. This was then reclined, the
dissection continuing towards the dihedral angle between
the atrium and the pulmonary artery. The distal part of the
left trunk then appeared as well as the division between the
circumﬂex coronary artery and anterior descending branch.
The proximal circumﬂex coronary artery was then exposed
and the ﬁrst ameroid constrictor placed around it (3.5mm,
Research Instruments, Lebanon, Oregon) just above the
ﬁrst lateral branch (Figure 2). The descending branch was
exposed, then a second constrictor of the same type was
placed just below the ﬁrst septal branch (Figure 2). After
closing up the pericardium, the ribs were closed surgically.
Ap l e u r a le x s u ﬄation and a positive expiratory pressure
enabled air to be emptied and to remove atelectasis in the
left lung. The muscle wall was closed after injection of a local
anaesthetic, such as Naropeine. An intravenous infusion of
an analgesic (100mg of ketoprofen) was administered as well
as an injection of aspirin (200mg) to activate antiplatelet
treatment. This treatment was continued per os for 10 days
in association with Cordarone (200mg/day).
2.5. Evaluation by Echocardiography. A Vivid 7 (GE Medical
Systems, Horten, Norway) was used to acquire echocardio-
graphic data with a 4-MHz transducer. All the evaluations
were performed at rest.Cardiology Research and Practice 3
Figure 2:Afterincisioninthethoraxinthe4-5thintercostalspace,thepericardiumisopened.Theleftatriumisreclined,theatrioventricular
groove dissected, and the circumﬂex branch of left coronary artery is exposed. The constrictor is placed around it. A second constrictor is
then placed around the left anterior descending artery.
DTDVG (mm) 33.75 +/− 3.3
48.81 +/− 10.46
47.25 +/− 3.12∗
106.5 +/− 16.6∗
55.33 +/− 5.93∗
154.67 +/− 35.47∗
Basal 1 month 2 months
Mitral insuﬃciency
5
10
15
90
HR
V
0.65
−0.65
VTDVG (mL)
Figure 3: One to 2 months after constriction, the left ventricle
dilates and a signiﬁcant mitral insuﬃciency appears.
To determine the percentage of thickening, the method
was performed using the following formula TeleDiastolic
Diameter—TeleSystolic Diameter/TeleDiastolic Diameter.
Results were expressed in percentage.
To study Wall motion score, the LV was divided into 12
segments assigned to coronary artery supply. Image anal-
ysis was performed by an experienced echocardiographer
unaware of swine disease, who analyzed stored 2D cine loops
in random order. Quad-screen display was used to view the
2D parasternal long-axis and short-axis views and apical
4-chamber, 2-chamber, and long-axis views at baseline.
Wall motion score was assessed using a side-by-side visual
assessment. The development of new or worsening resting
LV wall motion abnormalities in >1 contiguous segment of
thesamevascularterritorywasconsideredasignofinducible
ischemia. Segmental wall motion was scored as follows: 1 =
normal or hyperkinetic, 2 = hypokinetic, 3 = akinetic, and
4 = dyskinetic.
Formyocardialfunction,aconventionalechocardiogram
of the ejection fraction was carried out. Brieﬂy, the Simp-
son’s formula was used (TeleDiastolic Volume—TeleSystolic
Volume/TeleDiastolic Volume) and results were expressed in
percentage.
Tostudymyocardialperfusion,weusedcontrastechocar-
diography at rest with calculation of perfusion ﬂow-rate in
real-time mode together with a ﬂash sequence. A microbub-
ble solution of the type Sonovue∗ (BRACCO) was given by
central intravenous infusion to show the level of perfusion
at the level of the myocardial wall [15]. Myocardial signal
intensity (SI) was measured on end-systolic images at each
pulsing interval. Three transmural myocardial regions of
interest that encompassed the anterolateral, the septal, and
the inferior wall were selected. The SI was determined in
these regions of interest and averaged from 5 images for
each incremental delay. SI at every frame was ﬁtted to an
exponential function, y = A(1 − e−bt), where y is SI at any
given time, A is the SI plateau that reﬂects microvascular
cross-sectional area or myocardial blood volume, and b
is the slope of the reﬁlling curve that reﬂects myocardial
microbubble velocity. The product of A and b (A∗b)r e ﬂ ect s
the myocardial blood ﬂow.4 Cardiology Research and Practice
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Figure 4: Over time, a substantial decrease in the thickening and the mean wall motion score of ischemic myocardial walls can be observed;
∗P <. 01 compared to basal time.
Tools for quantifying 2-dimensional strain (speckle
tracking) enabled us, through a recording of conventional
b l a c ka n dw h i t ei m a g e si nt h ev a r i o u sz o n e s ,t oo b t a i nt h e
parameters of myocardial deformation. These deformations
depending on the orientation of acquisitions were expressed
in the form of circumferential, longitudinal, and radial
components closest to the orientation of the myocardial
ﬁbres. These components were exploited at rest as described
in [16]. The deformation data were obtained by automatic
measurement of the distance between 2 pixels of an LV
segment during the cardiac cycle and are independent of
angle.Thedatawerestoredandtransferredtoacomputerfor
postprocessing analyses. The recordings were analyzed with
Echopac software (GE Medical Systems).
2.6. Evaluation by Coronary Angiography. Coronary angiog-
raphy was used to monitor the progressive evolution of
stenosisofthecoronaryarteries,toassesstheintensityofﬂow
throughthestenoses,andtocheckcollateralityfromtheright
coronaryartery.Itwascarriedoutthroughthefemoralartery
u s i n ga4F r .c a t h e t e r .
2.7. Histological Analysis. After sacriﬁce, various fragments
from the anterior, lateral ischemic zones, as well as the
healthy zones were harvested, then ﬁxed in methanol as well
as cryopreserved. These various fragments were stained with
Masson’s trichrome stain. Analysis of inﬂammatory reaction
was carried out by labelling with myeloperoxydase, with CD
45, and with CD 3. Capillary density was performed by
immunostaining of endothelial cells with CD 31 [17].
2.8. Statistical Analysis. The results are expressed in mean ±
standard deviation. All the analyses were carried out using
the relevant software (Statview 5–1). Comparisons of the
continuous variables between 2 groups were carried out
using ANOVA. If a statistical diﬀerence was found, a t-test
was carried out. A value of P<. 05 was considered to be
signiﬁcant.
3. Results
3.1. Mortality. Twenty-seven pigs were operated for this
study. Two died during the procedure for implanting the
constrictors (1 from a tear in the left atrium, 1 from ven-
tricular ﬁbrillation). Ten died during the follow-up period.
Six died (25%) from congestive heart failure and 4 died
from cardiac rhythm disorder (probably VT, 16%)caused
suddenly. We were able to assess 15 animals for the present
study. Total mortality rate was 40%. In a preliminary study
and in the absence of programmed sacriﬁce (only with the
aim of studying survival in the longer term), all the animals
died at three months.
3.2. Assessment of Stenoses. The degree of stenosis was
assessed by immediate postoperative coronary angiography,
and at 1 and 2 months. No stenosis was seen in the
immediate postoperative examination. At 1 month, the
stenosesobservedbothonthecircumﬂexandontheanterior
descending branch were approximately 90%. The ﬂow was
scored TIMI 2, except for 1 case where the circumﬂex was
thrombosed. Similar results were observed at 2 months
with no worsening of the already existing stenoses. In
contrast, in our hand, we were never able to demonstrate
any collateralization on the follow-up angiographies with a
speciﬁc analysis from the right coronary artery.
3.3. Assessment of Cardiac Function and Myocardial Ischemia.
At 1 month, with identical results at 2 months, there was
signiﬁcant alteration in left ventricular function of around
30% to 35%. As shown in Table 1, this dysfunction was
accompaniedbyimportantmodiﬁcationsoftheLVgeometry
and dilation (as well as in LVTDV, LVTDD, E/Ea, Left
Atrial size, wall thickness; Table 1) and by signiﬁcant mitralCardiology Research and Practice 5
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Figure 5: (a) Echocardiographic visualisation of the development of radial and circumferential deformation in healthy and ischemic zones.
Quantiﬁcation of peaks in circumferential and radial strain in ischemic and control areas showed substantial anomalies in radial and
circumferential deformations alike, both on the anterior and lateral surface of the heart, with compensation marks on the inferior healthy
surface (∗P <. 01 compared to basal time). (b) Graphic representations of anomalies in radial and circumferential deformation in walls of
myocardium.
insuﬃciency(gradeIII/IV)wherethemechanismwasmixed,
because of restriction of movement of the posterior mitral
valve and by annular dilation (Figure 3, ∗P <. 05). A
signiﬁcant decrease in percentage of thickening (Figure 4,
38 ± 5% at basal time to 30 ± 4% at 1 month and to
14 ± 6% at 2 months after constriction in the anterior
zone, ∗P <. 01) as well as substantial alteration of the
mean wall motion score was found (Figure 4,1± 0.7 at
basal time to 3 ± 0.5 at 1 or 2 months after constriction
in anterior area with similar results in inferolateral zone,6 Cardiology Research and Practice
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Figure 6: Echocardiographic evidence of defects in perfusion after
injectionofcontrastmedium.Asshown,myocardialbloodﬂowwas
signiﬁcantly decrease in the anterior and lateral areas (∗P <. 05)
compared to the healthy zone (inferior wall of the left ventricle).
∗P <. 01 compared to basal time). The circumferential
and radial strain were obtained in the parasternal short-
axis view. Apical views were used to measure longitudinal
strain as well as in the anterior, lateral, and inferior wall.
Echocardiographic analysis consisted of measurement of the
peak of strain in the end-systolic phase within the ischemic
and the healthy zone (Figure 5(a)). Quantiﬁcation of peaks
(white arrows) in circumferential strain in end systole in
ischemic areas (yellow curve) and control areas (blue curve)
showed substantial anomalies in radial (e.g., 58 ± 11% at
basal time compared to 8 ± 1% at 2 months in the anterior
area, ∗P <. 01) and circumferential deformations (e.g., −17
± 1% at basal time compared to −2 ± 2% at 2 months
in the anterior area, ∗P <. 01) alike, both on the anterior
and lateral surface of the heart, with compensation marks
on the inferior (or healthy) surface (e.g., in circumferential
strain −13 ± 2% at basal time compared to −18 ± 2% at
2 months in the anterior area, ∗P <. 01, Figures 5(a) and
5(b), ∗P <. 01). These anomalies in function were coupled
with anomalies of perfusion observed in echocardiography
after injection of contrast medium. As shown in Figure 6,
there were perfusion defects in the anterior and lateral areas
(∗P <. 05) compared to the healthy zone (inferior wall of
the left ventricle) corresponding in a signiﬁcant decrease in
myocardial blood ﬂow.
3.4. Histological Assessment of the Ischemic Heart. After
sacriﬁce, the hearts were collected for histological analysis.
Staining with Masson’s trichrome stain enabled elimination
of the presence of infarction (Figure 7(a)). Immunostaining
of vessels (anti-CD 31, lectin) found a signiﬁcant reduction
in capillary density at the level of the anterior and lateral
surfaces compared with the healthy zone (Figure 7(b))
of approximately 30%. Immunostaining for inﬂammatory
cells in the ischemic zones found a moderate inﬂammatory
response with few CD 45 positive cells in the anterior and
inferior wall.
4. Discussion
Ischemic heart failure is a major cause of morbidity and
mortality in developed countries. Much progress has been
made, both in understanding the pathophysiological pro-
cesses involved and in the medical and surgical management
of these patients. However, many problems remain and
require the development of new concepts to improve the
prognosis for our patients. In this sense, cardiac surgeons,
in association with all the actors in health and research who
are involved in heart failure, play an essential role in trying to
manage this disease better. Developing experimental models
for ischemic heart failure is an important part in the pro-
gression of research in this ﬁeld. Our object was to develop
and deﬁne a preclinical model for ischemic heart failure in
a large animal. Our choice focused on the pig because of
the possible extensions for surgical treatment which could be
developed. In the literature, there is no model, to date, for
heart failure secondary to chronic ischemia. Many models
have been developed with the aim of making a ventricle
deﬁcient but they do not pertain to a process of chronic
ischemia. Whether they are models for infarction by ligature,
by embolization, by endocoronary balloon, by injection
with toxins, or by rapid rhythm electrical stimulization,
permanent myocardial ischemia cannot be superimposed
on any of them [18]. In our unit, we developed a model
for chronic myocardial ischemia by constriction (ameroid
constrictor) of the circumﬂex branch of left coronary artery
[19] .T h i sm o d e l ,a l r e a d yu s e db ym a n yr e s e a r c hc e n t r e s ,
oﬀers the possibility of creating ischemia in the inferior-
lateral wall of the left ventricle. Although interesting for
manyﬁelds,suchascelltherapy,forexample,[20–22],itdoes
not provide left ventricle dysfunction and cannot therefore
be used in the ﬁeld of heart failure. We hypothesized that
creating severe ischemia both in the anterior and in the
inferior-lateral region might be a good strategy for devel-
oping heart failure. We developed and deﬁned the model
for chronic ischemic heart failure by double constriction.
This model is viable and reproducible despite signiﬁcant
mortality.Chronicconstrictionhastheadvantageofbuilding
up progressively with the growth of the animal. Histological
analysis enabled us to avoid any underlying necrosis thus
eliminating dysfunction due to infarction. As evidence,
the myocardium is viable and the moderate inﬂammatory
response observed in the area at risk probably help for
angiogenesis. The tools required for assessing our model
were based ﬁrstly on coronary angiography, which showed
usanatomicallytheprogression ofthestenoses.Interestingly,
we were never able to demonstrate any collaterality from the
r i g h tc o r o n a r ya r t e r y .I nt h i sw a y ,w ec o u l dn o ts u p p o r ta n y
compensation from the right coronary artery in regional or
global function. The second tool for assessment was based
on echocardiography, at rest by analysis of perfusion and
deformation. We demonstrated that the myocardium pre-
sented a substantial alteration of perfusion but this remains
persistent. These defects in perfusion were accompanied byCardiology Research and Practice 7
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Figure 7: (a) Staining with Masson’s trichrome stain comparing a healthy zone (inferior wall of the left ventricle) with an ischemic
zone (anterior wall with similar results for lateral wall). No necrosis was found demonstrating the absence of myocardial infarction. (b)
Immunostaining with ﬂuorescence of lectin found signiﬁcant reduction in capillary density in anterior compared to the inferior wall.
Table 1: Morphometric and functional analysis at basal time and during the follow-up. LVTDD: Left Ventricle TeleDiastolic Dimension.
LVTDV: Left Ventricle TeleDiastolic Volume, dIVSW: diastolic InterVentricular Septal Wall, dPLVW: diastolic Posterior Left Ventricle Wall,
E/Ea: Peak mitral inﬂow velocity—E- and Early diastolic—Ea-peak myocardial velocities with Tissue Doppler Imaging, LAV: Left Atrial
Volume, WMS ant: Anterior Wall Motion Score, WMS inf: Inferior Wall Motion Score, and WMS Sept: Septal Wall Motion Score. Data are
in mean ± SD. ∗P <. 05, ∗∗P <. 01 compared to basal time.
Basal Time 1 month 2 months
LVTDD (mm) 33.75 ± 3.3 47.25 ± 3.12∗ 55.33 ± 5.93∗∗
LVTDV (mL) 48.81 ± 10.46 106.5 ± 16.6∗ 154.67 ± 35.47∗∗
dIVSW (mm) 7.73 ± 0.24 7.81 ± 1.2 8.67 ± 0.24∗
dPLVW (mm) 6.09 ± 0.21 7.38 ± 0.9∗ 7.53 ± 0.47∗
E/Ea 4 ± 0.3 7 ± 0.32∗ 9 ± 0.56∗
LAV (cm2)7 . 5 ± 2.06 12.30 ± 2.48∗ 16.84 ± 3.5∗∗
WMS ant 1 ± 0.7 3 ± 0.5∗ 3 ± 0.5∗
WMS inf 1 ± 0.4 2.5 ± 0.6∗ 3 ± 0.5∗
WMS Sept 1 2 2
morphometric modiﬁcations in the left ventricle with dila-
tion and without the appearance of myocardial infarction.
There were anomalies in the deformation of the ventricular
walls in the 3-dimensional areas in the ischemic zones. All
these elements are responsible for severe left ventricular
dysfunction. This experimental study was also designed
to ﬁnd out if assessment of 2-dimensional strain could
detect contraction abnormalities induced by ischemia in a
severe model of heart failure. Our results suggested that 2-
dimensional strain was reliable for detection of myocardial
contraction abnormalities under ischemic conditions at rest
at an earlier stage.
However, the study presented some several limitations.
Firstatall,weobservedanimportantrateofmortalityduring
the follow-up. This mortality was probably dependant on
the model but this high incidence of sudden death or end
stage heart failure represented a severe limitation to improve
our understanding of pathophysiology. Second, we have not
performed hemodynamic study and we could not evaluate
LVEDP which would be an important target in this model.
The LV ﬁlling pressures were only analyzed echographycally
with the ratio E/Ea. Finally, all the measurements were
performed at rest without dobutamine infusion. Histological
analysis had never demonstrated necrosis and myocardial8 Cardiology Research and Practice
infarction in the area at risk traducing the anatomical
integrity of the myocardial wall (viable myocardium). If 2-
dimensional strain analysis has clearly demonstrated its role
in the evaluation of our model at rest, our results could be
strengthened at stress.
We have therefore created a stable model for ischemic
heart failure and developed tools to deﬁne it. This model
could be used to assess new medications, new procedures for
echocardiographic analysis, to implement new procedures
for biventricular stimulation, or more speciﬁcally for sur-
geons as a basis for new techniques for surgical management
of ischemic heart failure.
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